Women's Health: Medicines in Pregnancy and Breastfeeding - Yenra

Review medicines before making changes

If you are planning pregnancy, are pregnant, or discover a pregnancy while taking medicine, discuss the treatment with your prescriber, pharmacist, or maternity-care team. Some medicines can cause harm, while stopping necessary treatment can also create risks. The CDC overview of medicine and pregnancy recommends talking with healthcare professionals before starting or stopping medicines.

Gather the exact product names, ingredients, strength, amount actually taken, route, frequency, and dates. Include occasional pain or cold remedies, creams, inhalers, injections, vitamins, and herbal products. A brand name alone may be insufficient because different versions can contain different ingredients.

Download a medicine-review worksheet (CSV). Record what you take rather than what you think the ideal regimen should be. Bring the packaging or photographs of labels when useful. This list is for discussion; it does not recommend doses or decide which medicines to continue.

Invented example: “I used a combination cold product twice before I knew I was pregnant” leaves important questions unanswered. The package ingredients, amounts, dates, reason for taking it, and estimated stage of pregnancy give a professional something concrete to assess. An exposure is not, by itself, evidence that harm occurred.

Understand what a label can—and cannot—say

U.S. prescription labeling moved away from the old pregnancy categories A, B, C, D, and X. The FDA's pregnancy and lactation labeling resources explain the narrative sections that address risk, clinical considerations, and supporting data. The old letters are not a current shortcut for choosing treatment.

On a small screen, scroll the table sideways to read all columns.

Absence of a demonstrated risk is different from strong evidence that a risk is absent. Ask how much human experience exists, whether findings concern the same dose and stage of pregnancy, and whether the underlying illness might explain some of the observed outcomes. A list labeled “safe medicines” cannot resolve those questions for every person.

The FDA's patient guide to medicine and pregnancy also cautions against assuming that “natural” means safe. Herbal and dietary products belong in the review alongside prescriptions. Use online information to prepare questions, not to substitute a supplement for treatment or abruptly stop a medicine.

Breastfeeding involves a different exposure

A medicine's use during pregnancy does not automatically determine its use while breastfeeding. The assessment considers the medicine, possible transfer into milk, the infant, and the parent's treatment needs. Tell the care team if your baby was premature or had jaundice, as this can affect the advice. The NHS guide to breastfeeding and medicines explains why all professionals prescribing or supplying medicines should know that you are breastfeeding.

LactMed, the Drugs and Lactation Database, summarizes published information on levels in milk and infant blood, possible effects, and alternatives when appropriate. It provides referenced evidence for a discussion with a clinician or pharmacist. A database entry does not assess your baby's health or reconcile every medicine you take.

Ask whether any infant monitoring is needed and what changes should prompt contact. If someone recommends changing treatment or interrupting breastfeeding, ask for the reason, expected duration, and a clear plan for both feeding and the condition being treated. Avoid guessing that spacing a dose around a feed solves every exposure question.

Turn the conversation into an agreed plan

Ask the prescriber to explain the options in terms you can compare: continuing the current treatment, changing it, or treating the condition another way. Record who will coordinate decisions when more than one specialist is involved. Revisit the plan if your health, pregnancy stage, medicines, or feeding circumstances change.

• What problem does each medicine treat, and what happens if it is not treated?
• What evidence applies to my situation?
• Is a change needed, and who will supervise it?
• What monitoring is planned for me or the baby?
• Whom should I contact about a missed dose, side effect, or new over-the-counter product?

Pregnancy exposure registries collect information about outcomes after medicines or vaccines are used during pregnancy. They can help address evidence gaps, but participation does not establish that an exposure is harmless. The FDA registry list describes available studies and makes clear that FDA does not operate or endorse the listed registries. Ask the study team what participation involves, how information is protected, and whether you are eligible.